MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 4.216
AS - Asia 1.794
EU - Europa 1.328
SA - Sud America 278
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.665
Nazione #
US - Stati Uniti d'America 4.111
SG - Singapore 602
CN - Cina 451
IT - Italia 337
VN - Vietnam 251
DE - Germania 235
BR - Brasile 218
PL - Polonia 170
HK - Hong Kong 132
FI - Finlandia 125
GB - Regno Unito 116
UA - Ucraina 97
TR - Turchia 87
BD - Bangladesh 71
CA - Canada 61
FR - Francia 61
JP - Giappone 52
SE - Svezia 48
RU - Federazione Russa 44
IN - India 35
MX - Messico 30
ID - Indonesia 29
NL - Olanda 28
AR - Argentina 23
BE - Belgio 17
PK - Pakistan 14
IQ - Iraq 12
ZA - Sudafrica 11
EC - Ecuador 9
ES - Italia 9
IE - Irlanda 9
LT - Lituania 9
TN - Tunisia 9
UZ - Uzbekistan 8
VE - Venezuela 8
MA - Marocco 7
MY - Malesia 7
CO - Colombia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CZ - Repubblica Ceca 5
KR - Corea 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
BB - Barbados 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.665
Città #
Dallas 810
Ashburn 506
Singapore 377
Fairfield 264
San Jose 249
Woodbridge 232
Ann Arbor 192
Warsaw 168
Beijing 157
Houston 150
Chandler 142
Seattle 136
Santa Clara 133
Munich 129
Hong Kong 121
Wilmington 119
Jacksonville 115
Ferrara 100
New York 94
Cambridge 92
Helsinki 79
Ho Chi Minh City 72
Los Angeles 69
Hanoi 50
Tokyo 50
Izmir 43
Nanjing 40
Dong Ket 34
Milan 34
Lauterbourg 31
Princeton 28
Council Bluffs 27
Shanghai 27
São Paulo 26
The Dalles 25
Boardman 23
Bologna 22
Dearborn 20
Jakarta 19
Brussels 17
Chicago 17
Toronto 17
Mexico City 16
Brooklyn 15
Fuzhou 15
Mcallen 14
San Diego 14
Buffalo 13
Montreal 13
Montréal 13
Padova 13
Amsterdam 12
Frankfurt am Main 12
Moscow 12
Turku 12
Da Nang 11
London 11
Phoenix 11
Atlanta 10
Haiphong 10
Nanchang 10
Orem 10
Rio de Janeiro 10
Stockholm 10
Boston 9
Denver 9
Dublin 9
Hefei 9
Poplar 9
Columbus 8
Lahore 8
Tashkent 8
Chennai 7
Falls Church 7
Rome 7
Bremen 6
Changsha 6
Dhaka 6
Jiaxing 6
Johannesburg 6
Nuremberg 6
Auburn Hills 5
Baghdad 5
Brasília 5
Florence 5
Jyväskylä 5
Lappeenranta 5
Manchester 5
Mumbai 5
San Francisco 5
Shenyang 5
Tianjin 5
Addison 4
Ankara 4
Augusta 4
Bari 4
Biên Hòa 4
Boydton 4
Brescia 4
Bến Tre 4
Totale 5.536
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 995
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 376
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 369
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 292
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 290
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 247
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 231
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 228
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 222
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 221
Pharmacological characterization of tachykinin tetrabranched derivatives 214
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 211
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 210
null 205
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 205
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 204
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 200
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 194
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 189
NOP receptor pharmacological profile – A dynamic mass redistribution study 182
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 181
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 178
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 176
Pharmacological Assays for Investigating the NOP Receptor 174
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 151
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment 144
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 140
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 137
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 128
Pharmacological characterization of naloxegol: In vitro and in vivo studies 112
null 110
null 105
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 104
null 103
null 78
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 74
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 70
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 68
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 33
Comprehensive transduceromic profiling of NOP receptor ligands at different Gα subunits 11
Totale 7.762
Categoria #
all - tutte 28.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 972
Totale 29.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/2022265 24 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024288 18 23 5 7 14 58 14 57 3 9 17 63
2024/20251.048 29 39 80 32 91 123 80 70 172 89 138 105
2025/20263.629 317 286 819 362 395 217 344 173 240 301 152 23
Totale 7.762